IOWA ONCOLOGY RESEARCH ASSOCIATION
[ Home ] [ Treatment ] [ Control & Prevention ] [ STAR ] [ SELECT ] [ Physicians ] [ Contact Us ] [ Helpful Links ]

Genitourinary Cancer Research Studies

ADJUVANT RENAL CELL
E2805   ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma

BLADDER
R0524   A Phase I / II Trial of a Combination of Paclitaxel and Trastuzumab with Daily Irradiation or Paclitaxel Alone with Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates with Muscle-Invasive Bladder Cancer

ADVANCED / METASTATIC RENAL CELL
E2804   The BeST Trial: A Randomized Phase II Study of VEGF, RAF kinase, and mTOR Combination Targeted Therapy (CTT) with Bevacizumab, Sorafenib and Temsirolimus in Advanced Renal Cell Carcinoma

E4805   Phase II Study to Determine the Effect of 2 Different Doses of VEGF Trap in Metastatic Renal Cell Carcinoma

PROSTATE
E3803   A Phase II Study of a Weekly Schedule of BMS-247550 for Patients with Hormone Refractory Prostate Cancer

E3805   CHAARTED: ChemoHormonal Therapy versus Androgen Ablation Randomized Trial for Extensive Disease Prostate Cancer

E5805   A Phase II Trial of E7389 (Halichondrin B Analog) in Patients with Metastatic Hormone Refractory Prostate Cancer

R0534   Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPORT) in Prostate Cancer patients with a Rising PSA After Radical Prostatectomy

S0421   Phase III Study of Docetaxel and Atrasentan Versus Docetaxel and Placebo for Patients with Advanced Hormone Refractory Prostate Cancer